The impact of acid-base disorders in patients with chronic pancreatitis comorbid with type 2 diabetes on long-term quality of life and possible improvement with small volume infusion therapy

  • Received 14.12.2021

  • Revised 23.01.2022

  • Accepted 23.02.2022



  • 1,094 Views

  • Retrieved from Volume 3, No. 4, 2021

  • Pages 95-100

Summary. The article presents the results of the study of metabolic endogenous intoxication indexes (MEI) reflecting intoxication by organic compounds influencing the change of physiological pH balance and their correlation with the presence and severity of chronic pain syndrome and quality of life criteria. The dynamics of these indexes and improvement of QOL on the background of the suggested scheme of small volume infusion detoxification therapy (SWIDT) by hyperosmolar balanced crystalloid (HSC) containing components with reserve alkalinity in the section of 30-day period were researched. The aim of the study – to evaluate the therapeutic effect of SWIT on the severity of pH abnormalities as well as the effect of SWIT on the severity of chronic pain syndrome and related aspects of quality of life in patients with CP in comorbidity with T2DM. Materials and Methods. 115 patients divided into 5 groups were examined: Group 1 – 20 patients without complaints on the gastrointestinal tract, Group 2 – 30 patients with CP, Group 3 – 20 CP patients with concomitant T2DM received protocol treatment (PT), Group 4 and 5 – CP patients with concomitant T2DM, including 21 patients received PT with a course of SWIT for 3 days, and 24 patients – SWIT course for 5 days. The concentration of lactate and pyruvate in blood plasma was determined, the lactate/pyruvate ratio was calculated, the concentration of bicarbonates in blood plasma was determined, pain was determined by the QLQ-C30 and PAN28 questionnaires, pain syndrome severity was determined by the visual analogue scale (VAS). Statistical processing of the obtained data was performed using Microsoft Excel 2016 and Statistica 13.0. Results. A positive therapeutic effect on the dynamics of the level of mEI markers and COPD disorders in patients with CP with concomitant T2DM has been proved, which indicates the positive effect of the SWIT scheme in the program of complex treatment. A clear dependence of the rate of normalization of these parameters on the duration of the SWIT course was revealed. Conclusions. 1 Statistically significant increase of objective markers of COS impairment due to MEI (lactate, lactate/pyruvate ratio) in CP patients with concomitant T2DM in comparison with the same in isolated CP was revealed (p<0.05). Strong correlations between markers of mEI and pH disturbance towards metabolic acidosis mediated by lactate/pyruvate ratio and bicarbonate content were found. A higher level of efficiency of SWIT-5 application in complex therapy in comparison with MOIT-3 program has been established. It is proved that normalization of the specified indexes directly correlates with duration of the MOIT course.

chronic pancreatitis, type 2 diabetes mellitus, endogenous metabolic intoxication, small volume infusion detoxification therapy, disorders of acid-base balance, lactate; pyruvate, bicarbonate deficiency, metabolic acidosis, pain, quality of life

https://doi.org/10.11603/bmbr.2706-6290.2021.4.12655

[1] Melamed P, Melamed F. Chronic metabolic acidosis destroys  pancreas.  Biotherapy  Clinic  of  San  Francisco, USA. JOP. 2014;15(6): 552-60. Available from: https://doi.org/10.6092/1590-8577/2854.

[2] Cruz-Monserrate  Z,  Gumpper  K,  Pita  V,  Hart  PA, Forsmark  C,  Whitcomb  DC,  et  al.  Biomarkers  of  chronic pancreatitis: a systematic literature review. Pancreatology. 2021;21(2): 323-33. Available from: https://doi.org/10.1016/j.pan.2021.01.006.

[3] Lomakina EY, Taratina OV, Belousova EA. Chronic pancreatitis and diabetes mellitus: a review of the literature. Almanac  Clin  Med.  2019;47(6):  525-34.  Available  from: https://doi.org/10.18786/2072-0505-2019-47-075.

[4] Kellerund J, Layer P. Diagnosis of pancreatic exocrine insufficiency   in   chronic   pancreatitis.   Pancreapedia. 2015;2015:  1-7.  Available  from:  https://doi.org/10.3998/panc.2015.37.

[5] Goulden  MR.  The  pain  of  chronic  pancreatitis:  a persistent  clinical  challenge.  Br  J  Pain.  2013;7(1):  8-22. Available from: https://doi.org/10.1177/2049463713479230.

[6] Warshaw AL, Banks PA, Fernández-Del Castillo C. AGA Technical review: treatment of pain in chronic pancreatitis. Gastroenterology.  1998;115(3):  765-76.  Available  from: https://doi.org/10.1016/s0016-5085(98)70157-x.

[7] Ewald  N,  Hardt  PD.  Diagnosis  and  treatment of  diabetes  mellitus  in  chronic  pancreatitis.  World  J Gastroenterol.  2013;19(42):  7276-81.  Available  from: https://doi.org/10.3748/wjg.v19.i42.7276.

[8] Forsmark CE. Management of chronic pancreatitis. Gastroenterology.  2013;144(6):  1282-91.  Available  from: https://doi.org/10.1053/j.gastro.2013.02.008.

[9] Ito T, Ishiguro H, Ohara H, Kamisawa T, Sakagami J, Sata N, et al. Evidence-based clinical practice guidelines for chronic pancreatitis 2015. J Gastroenterol. 2016;51(2): 85-92. Available from: https://doi.org/10.1007/s00535-015-1149-x.

[10] Melki G, Laham L, Karim G, Komal F, Kumar V, Barham S, et  al.  Chronic  pancreatitis  leading  to  pancreatogenic diabetes presenting in diabetic ketoacidosis: a rare entity. Gastroenterol  Res.  2019;12(4):  208-10.  Available  from: https://doi.org/10.14740/gr1203.

[11] Petrov MS. Post-pancreatitis diabetes mellitus: prime time for secondary disease. Eur J Endocrinol. 2021;184(4): R137-49.  Available  from:  https://doi.org/10.1530/EJE-20-0468.

[12] Steinberg J, Carlson L. Type 2 diabetes therapies: A STEPS approach. Am Fam Physician. 2019;99(4): 237-43.  Available  from:  https://www.aafp.org/afp/2019/0215/p237.html#:~:text=Type%202%20Diabetes%20Therapies%3A%20A%20STEPS%20Approach%20,Exenatide%20weekly%3A%20...%20%204%20more%20rows%20.

[13] Wu Y, Dong Y, Atefi M, Liu Y, Elshimali Y, Vadgama JV. Lactate,  a  neglected  factor  for  diabetes  and  cancer interaction.  Mediators  Inflamm.  2016;2016:  6456018. Available from: https://doi.org/10.1155/2016/6456018.

[14] [On  approval  and  implementation  of  medical  and technological  documents  for  standardization  of  medical care  for  chronic  pancreatitis:  adapted  clinical  guideline 2014. 2. Order of the Ministry of Health of Ukraine dated September 10, 2014 No. 6384]. Available from: http://uoz-chernigov.at.ua/publ/normativna_baza/medicina/nakaz_moz_ukrajini_vid_10_09_2014_638/7-1-0-600. Ukrainian.

[15] Halushko  OA,  Nedashkovsky  SM.  [Intoxication syndrome  in  the  practice  of  internal  diseases:  the  role and place of Reosorbilakt]. Hazeta «Novyny medytsyny i farmatsii».  2020;3(715). Available  from:  www.mif-ua.com/archive/article/49014. Ukrainian.